title: Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.
abstract: We demonstrate here that the E2F1 induced by DNA damage can bind to and promote the apoptotic function of p53 via the cyclin A binding site of E2F1. This function of E2F1 does not require its DP-1 binding, DNA binding, or transcriptional activity and is independent of mdm2. All the cyclin A binding E2F family members can interact and cooperate with p53 to induce apoptosis. This suggests a novel role for E2F in regulating apoptosis in response to DNA damage. Cyclin A, but not cyclin E, prevents E2F1 from interacting and cooperating with p53 to induce apoptosis. However, in response to DNA damage, cyclin A levels decrease, with a concomitant increase in E2F1-p53 complex formation. These results suggest that the binding of E2F1 to p53 can specifically stimulate the apoptotic function of p53 in response to DNA damage.
authors.affiliation: Ludwig Institute for Cancer Research, Imperial College School of Medicine, London W2 1PG, United Kingdom.
authors.forename: Jung-Kuang
authors.initials: JK
authors.lastname: Hsieh
authors.forename: Damian
authors.initials: D
authors.lastname: Yap
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: O'Connor
authors.forename: Valentina
authors.initials: V
authors.lastname: Fogal
authors.forename: Lynn
authors.initials: L
authors.lastname: Fallis
authors.forename: Florence
authors.initials: F
authors.lastname: Chan
authors.forename: Shan
authors.initials: S
authors.lastname: Zhong
authors.forename: Xin
authors.initials: X
authors.lastname: Lu
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D001665:Binding Sites; D018797:Cell Cycle Proteins; D002469:Cell Separation; D019925:Cyclin A / Q000378:metabolism*; D004249:DNA Damage; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D050684:E2F Transcription Factors; D050687:E2F1 Transcription Factor; D005434:Flow Cytometry; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D009687:Nuclear Proteins; D011233:Precipitin Tests; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2; D051736:Proto-Oncogene Proteins c-mdm2; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D014466:Ultraviolet Rays; D051028:bcl-2-Associated X Protein
chemical_list: D018797:Cell Cycle Proteins; D019925:Cyclin A; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D050687:E2F1 Transcription Factor; C493753:E2F1 protein, human; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D051028:bcl-2-Associated X Protein; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2